In addition, CLEC9A expression in myeloid cells of IBM samples was significantly correlated with KLRG1 expression in T & NK cells of those samples, and to a greater extent (by ρ) than CD1C and LAMP3 (Figure 3B). This evidence concerns the gene CLEC9A and inclusion body myositis.